-
Uncategorized3 weeks agoA federal office of men’s health has never been closer, yet it’s likely still years away
WASHINGTON — Just before he was sworn in as assistant secretary for health at the end of 2025, Admiral Brian Christine — a urologist whose practice...
-
Uncategorized3 weeks ago
BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions
Recorded at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with BioAge co-founder and CEO Kristen Fortney on aging biology,...
-
Uncategorized3 weeks agoOpinion: Check-in and intake at the doctor’s office are perfect for AI
I was the only person seated in the waiting room of an internal medicine specialty clinic for blood pressure issues. The day before the appointment I...
-
Uncategorized3 weeks agoMass General Brigham says it is saving more lives. Some doctors aren’t so sure.
BOSTON — In a meeting for Mass General Brigham doctors in November 2024, Dr. Giles Boland, president of Brigham and Women’s Hospital, laid out the vision for becoming...
-
Uncategorized3 weeks ago
Constructing artificial methylotrophic S. cerevisiae for chondroitin sulfate production using a multidimensional combinatorial strategy
Constructing artificial methylotrophic S. cerevisiae for chondroitin sulfate production using a multidimensional combinatorial strategy
-
Uncategorized3 weeks ago
PURE makes PURE: reconstitution of the PURE cell-free system from self-synthesized proteins
Post Content
-
Uncategorized3 weeks agoAI Designs Miniprotein Switches for GPCR Targeting
AI Designs Miniprotein Switches for GPCR Targeting
-
Uncategorized3 weeks agoSTAT+: Closely watched experimental Parkinson’s drug fails key clinical trial
Biogen and Denali Therapeutics said Thursday that their experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial, dealing a...
-
Uncategorized3 weeks agoSTAT+: 3 burning questions senators had for the NIH director
Thursday’s Senate Appropriations Committee hearing was intended to focus on President Trump’s proposed budget for the National Institutes of Health’s fiscal year 2027 budget. Instead, many...
-
Uncategorized3 weeks ago
#ASCO26: Merck partner Kelun outlines Phase 3 lung cancer success in China study
Merck partner Kelun-Biotech fleshed out a Phase 3 win in lung cancer from a study in China for the experimental antibody-drug conjugate sac-TMT, raising hopes that...
STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
